Australia markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
41.47-1.75 (-4.05%)
At close: 04:00PM EDT
40.68 -0.79 (-1.90%)
After hours: 05:36PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-55,594
-58,293
-63,059
-32,672
-6,784
-
Depreciation & amortisation
2,034
1,955
841
113
13
-
Stock-based compensation
20,157
20,005
17,203
6,910
72
-
Change in working capital
-10,301
-6,554
4,276
8,842
389
-
Accounts receivable
-
-
0
8,000
-8,000
0
Accounts payable
-72
277
-294
2,139
14
-
Other working capital
-53,263
-52,425
-49,367
-18,458
-4,369
-
Other non-cash items
-
-
-
-
1,941
233
Net cash provided by operating activities
-51,501
-50,575
-42,922
-16,976
-4,369
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,762
-1,850
-6,445
-1,482
-
-
Purchases of investments
-424,178
-317,344
-294,389
-473,626
0
-
Sales/maturities of investments
279,750
278,000
359,100
134,145
0
-
Net cash used for investing activities
-146,190
-41,194
58,266
-340,963
0
-
Cash flows from financing activities
Common stock issued
377,044
56,530
0
204,167
0
-
Net cash used provided by (used for) financing activities
380,139
59,548
500
386,524
11,524
-
Net change in cash
182,448
-32,221
15,844
28,585
7,155
-
Cash at beginning of period
31,171
52,242
36,398
7,813
658
-
Cash at end of period
213,619
20,021
52,242
36,398
7,813
-
Free cash flow
Operating cash flow
-51,501
-50,575
-42,922
-16,976
-4,369
-
Capital expenditure
-1,762
-1,850
-6,445
-1,482
-
-
Free cash flow
-53,263
-52,425
-49,367
-18,458
-4,369
-